SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
Ford and Geely Explore Strategic Manufacturing Partnership in Europe 
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
Instagram Outage Disrupts Thousands of U.S. Users 
Washington Post Publisher Will Lewis Steps Down After Layoffs 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning 
SAN DIEGO, Jan. 11, 2017 -- Bionano Genomics, the leader in physical genome mapping, today announced 36 posters and workshops demonstrating how using next-generation mapping (NGM) to reveal true genome structure uniquely enables significant advances in plant and animal research. The posters and workshops, presented by prominent researchers from academic and industrial institutions, will be presented at the upcoming International Plant & Animal Genome (PAG) XXV Conference January 14 – 18, 2017 in San Diego, California.
Bionano’s downloadable 2017 Brochure on PAG activities includes details and logistics for each of the 36 posters and workshops on NGM that will be presented, including a Bionano-sponsored workshop that highlights how large genomic structural variations can reveal what is missing in genomic research. The workshop highlights advances in genomic research performed in areas relevant to evolutionary, crop, and breeding biology.
| Title: | Next-Generation Mapping Reveals Large Structural Variations: So What? |
| Date/Time: | Monday, January 16th from 6:10 – 8:20 p.m. PST |
| Location: | Pacific Salon 3, Town & Country Hotel, San Diego, CA |
Erik Holmlin, Ph.D., CEO of Bionano, commented, “A large and growing number of researchers are benefiting from Bionano, as demonstrated by the abundance of findings discovered using NGM and being presented at PAG this year. NGM is an essential tool for researchers to identify what is missing in their research via the mapping of large-scale structural variations, which are critical for gaining a deeper understanding of biology and achieving more actionable results, and which are mostly undetectable by other technologies.”
Learn more by visiting Bionano’s Booth # 331 at the PAG XXV and visiting www.bionanogenomics.com.
About Bionano Genomics
Bionano Genomics, Inc., the leader in next-generation mapping (NGM), provides customers with genome analysis tools that advance human, plant and animal genomics and accelerate the development of clinical diagnostics. The Company’s Irys® System uses NanoChannel arrays integrated within the IrysChip® to image DNA at the single-molecule level with average single-molecule lengths of about 350,000 base pairs, which leads the genomics industry. The long-range genomic information obtained with the Irys System helps decipher complex DNA involving repeats, which are the primary cause of inaccurate and incomplete genome assembly.
On its own, next-generation mapping with the Irys System enables detection of structural variants, many of which have been shown to be associated with human disease as well as complex traits in plants and animals. As a companion to next-generation sequencing (NGS), next-generation mapping with the Irys System integrates with sequence assemblies to create contiguous hybrid scaffolds that reveal the highly informative native structure of the chromosome.
Only Bionano provides long-range genomic information with the cost-efficiency and throughput to keep up with advances in next-generation sequencing.
The Irys System has been adopted by a growing number of leading institutions around the world, including: National Cancer Institute (NCI), National Institutes of Health (NIH), Wellcome Trust Sanger Institute, BGI, Garvan Institute, Salk Institute, Mount Sinai and Washington University. Investors in the Company include Domain Associates, Legend Capital, Novartis Venture Fund and Monashee Investment Management.
For more information, please visit www.BionanoGenomics.com.
Notes: Bionano Genomics is a trademark of Bionano Genomics, Inc. Any other names of actual companies, organizations, entities, products or services may be the trademarks of their respective owners.
Contact The Ruth Group Kirsten Thomas [email protected] (508) 280-6592
